Next Article in Journal / Special Issue
Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on “Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. Diagnostics 2023, 13, 2299”
Previous Article in Journal
Cross-Silo, Privacy-Preserving, and Lightweight Federated Multimodal System for the Identification of Major Depressive Disorder Using Audio and Electroencephalogram
Previous Article in Special Issue
Diagnostic Precision in Lyme borreliosis: Assessing VlsE and C6 Antigens in a Pediatric Cohort
 
 
Comment
Peer-Review Record

What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. Diagnostics 2023, 13, 2299

Diagnostics 2024, 14(1), 41; https://doi.org/10.3390/diagnostics14010041
by Hiroyasu Ishikura
Reviewer 1:
Diagnostics 2024, 14(1), 41; https://doi.org/10.3390/diagnostics14010041
Submission received: 12 September 2023 / Revised: 8 November 2023 / Accepted: 11 December 2023 / Published: 25 December 2023
(This article belongs to the Special Issue A Useful Diagnostic Method: Blood Test)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Comments for "Comment":

Honestly, I do not see any conflict in the presented comment. It seems to me that its author expressed his desire to share information on this topic. It is only the last paragraph that seems puzzling: “…I would like to advise that the title of Table 1 does not reflect the contents of this table and should be considered changing.” In my opinion, the contents of the table correspond to its title. It is not clear what the discrepancy is. The author should be able to explain and suggest their own version of the title. After that, the “Comment” can be accepted for publication.

 

Comments for "Reply":

There is no subject for discussion, since there are no comments or contradictions on the substance of the issue. Therefore, “Comment” and “Reply” look like an exchange of pleasantries and information. I also have no comments; the answer may be accepted for publication.

Author Response

First of all, I apologize for the delayed response.

I want to express my gratitude for your valuable advice. I did bring up a concern regarding the title provided in Table 1 below.

This was because I rarely come across table titles of this nature.

However, if the reviewers ultimately determine that this title is appropriate, I would like to withdraw the comment made in the last paragraph, which reads as follow "Finally, I would like to advise that the title of Table 1 does not reflect the contents of this table and should be considered changing.''

Please remove this comment.

Back to TopTop